Dan Luo

Dan Luo

Auto-generated profile, based on publicly available information

Dan Luo

School of Basic Medical Sciences Chengdu University of Traditional Chinese Medicine Chengdu People's Republic of China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JXJinghui Xie
Jinghui Xie
DLDan Luo
Dan Luo
PXPengfei Xing
Pengfei Xing
WDWeijun Ding
Weijun Ding
Ferroptosis, an iron-dependent programmed mechanism of cell death that is driven by lipid peroxidation, is an important pathogenic factor in oncological and non-oncological disorders. Dysregulation of iron and lipid metabolism profoundly influences disease progression through ferroptosis modulation. Signal transducer and activator of transcription 3 (STAT3), a transcriptional regulator, regulates ferroptosis by binding to promoters of key molecules such as solute carrier family 7 member 11 (SLC7A11), glutathione peroxidase 4 (GPX4), and ferritin heavy chain 1 (FTH1). In this review, we described the role of STAT3 in supporting tumors survival by suppressing ferroptosis in malignancies, and bidirectionally regulating ferroptosis in non-tumors to regulate the development of the disease. We also reported emerging therapeutic strategies that target STAT3-mediated ferroptosis, including natural phytochemicals, inhibitors, and nanotechnology-enabled drug delivery systems. These advancements deepen the mechanistic understanding of ferroptosis regulation, and provide new theoretical bases and strategies to treat ferroptosis-related diseases.

8 July 2023 in Phytotherapy Research
Verified
Journal Article
Closed access
DLDan Luo
Dan Luo
BYBaili Yu
Baili Yu
SSShoukai Sun
Shoukai Sun
BCBonan Chen
Bonan Chen
HHHarsh Vivek Harkare
Harsh Vivek Harkare
SSShihua Shi
Shihua Shi